Pamela Mehta, MD
Orthopedic Surgery · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Looking this up.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Mehta’s office to ask if they take your plan before you enroll.
Original Medicare doctor bills
$48,665
Medicare paid this office $48,665 for 131 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| New patient visit (45+ min) | 93 | $13,394 | $144 |
| Return visit (30+ min) | 64 | $12,575 | $119 |
| Aspiration and/or injection of fluid from large joint | 33 | $3,430 | $54 |
| X-ray of knee, 4 or more views | 22 | $1,503 | $48 |
| Short return visit (20+ min) | 16 | $1,495 | $79 |
See all 10 services
| New patient visit (45+ min) | 93 | $13,394 | $144 |
| Return visit (30+ min) | 64 | $12,575 | $119 |
| Aspiration and/or injection of fluid from large joint | 33 | $3,430 | $54 |
| X-ray of knee, 4 or more views | 22 | $1,503 | $48 |
| Short return visit (20+ min) | 16 | $1,495 | $79 |
| X-ray of shoulder, minimum of 2 views | 25 | $1,007 | $34 |
| X-ray of knee, 3 views | 14 | $756 | $42 |
| X-ray of shoulder blade | 26 | $746 | $23 |
| X-ray of hand, 2 views | 13 | $505 | $32 |
| Injection, methylprednisolone acetate, 1 mg | 36 | $421 | None |
Procedures Medicare counted
| Knee replacement | 1-10 | None |
| Lower limb (leg) arthroscopy (minimally invasive joint repair) | 1-10 | None |
Who their Medicare patients are
131 Original Medicare patients in 2024. Average age 76 · Women 62% · Health risk score 0.80. At or below the middle of the specialty; the typical orthopedic surgery clinician is at 1.13.
Conditions among them: High blood pressure 69% · Coronary heart disease 24% · Diabetes 22% · Depression 18% · Cancer 17% · Atrial fibrillation 17% · Chronic kidney disease 14%.
The office billed $164,965, Medicare allowed $64,085 and paid $48,665; for 4,546 services of 45 kinds; $490 of it was for drugs given in the office and $48,176 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 131 | 4,546 | 76 | 0.80 | $164,965 | $48,665 |
| 2023 | 108 | 423 | 74 | 0.89 | $113,800 | $34,652 |
| 2022 | 109 | 622 | 74 | 0.78 | $173,180 | $42,267 |
| 2021 | 105 | 1,705 | 75 | 0.84 | $263,250 | $78,837 |
| 2020 | 113 | 1,481 | 74 | 1.03 | $269,336 | $71,251 |
| 2019 | 122 | 2,333 | 73 | 1.04 | $367,285 | $87,618 |
| 2018 | 169 | 2,347 | 72 | 0.99 | $322,808 | $75,864 |
| 2017 | 175 | 889 | 73 | 0.99 | $230,269 | $60,436 |
| 2016 | 73 | 136 | 66 | 1.35 | $77,420 | $16,739 |
| 2015 | 11 | 18 | 68 | 1.04 | $15,846 | $2,728 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 9 services
| New patient visit (45+ min) | 73 | $10,872 | $149 |
| Return visit (30+ min) | 58 | $9,819 | $118 |
| Aspiration and/or injection of fluid from large joint | 27 | $2,283 | $59 |
| X-ray of knee, 4 or more views | 25 | $1,163 | $39 |
| Short return visit (20+ min) | 12 | $1,108 | $79 |
| X-ray of hand, 2 views | 16 | $406 | $21 |
| X-ray of shoulder, minimum of 2 views | 16 | $396 | $20 |
| Injection, methylprednisolone acetate, 80 mg | 29 | $382 | None |
| X-ray of shoulder blade | 15 | $283 | $15 |
2022: 9 services
| Return visit (30+ min) | 65 | $11,280 | $123 |
| New patient visit (45+ min) | 47 | $7,277 | $155 |
| Aspiration and/or injection of fluid from large joint | 32 | $3,224 | $54 |
| Short return visit (20+ min) | 26 | $2,512 | $84 |
| X-ray of knee, 3 views | 24 | $1,312 | $36 |
| X-ray of shoulder, minimum of 2 views | 20 | $664 | $27 |
| X-ray of shoulder blade | 18 | $450 | $20 |
| X-ray of hand, 2 views | 12 | $399 | $27 |
| Injection, methylprednisolone acetate, 80 mg | 27 | $398 | None |
2021: 12 services
| Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg | 12 | $27,363 | None |
| Return visit (30+ min) | 54 | $10,182 | $126 |
| Short return visit (20+ min) | 56 | $8,042 | $86 |
| Aspiration and/or injection of fluid from large joint | 40 | $5,323 | $52 |
| New patient visit (30+ min) | 38 | $4,141 | $109 |
| New patient visit (45+ min) | 13 | $2,091 | $161 |
| X-ray of knee, 3 views | 28 | $1,481 | $44 |
| X-ray of knee, 4 or more views | 15 | $890 | $49 |
| X-ray of shoulder, minimum of 2 views | 19 | $806 | $37 |
| Injection, methylprednisolone acetate, 80 mg | 31 | $503 | None |
| X-ray of shoulder blade | 18 | $495 | $25 |
| Injection, dexamethasone sodium phosphate, 1 mg | 11 | $3 | None |
2020: 12 services
| Short return visit (20+ min) | 72 | $8,029 | $66 |
| Return visit (30+ min) | 42 | $6,251 | $102 |
| Aspiration and/or injection of fluid from large joint | 43 | $4,662 | $50 |
| New patient visit (30+ min) | 28 | $2,489 | $89 |
| X-ray of knee, 3 views | 36 | $2,169 | $40 |
| New patient visit (45+ min) | 13 | $1,883 | $145 |
| X-ray of both knees while standing | 28 | $1,178 | $39 |
| X-ray of shoulder, minimum of 2 views | 18 | $691 | $35 |
| X-ray of shoulder blade | 19 | $604 | $29 |
| Injection, methylprednisolone acetate, 80 mg | 35 | $545 | None |
| X-ray of hand, 2 views | 13 | $474 | $28 |
| Injection, dexamethasone sodium phosphate, 1 mg | 28 | $5 | None |
2019: 12 services
| Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg | 18 | $26,672 | None |
| Short return visit (20+ min) | 73 | $11,576 | $68 |
| Aspiration and/or injection of fluid from large joint | 55 | $6,403 | $47 |
| New patient visit (30+ min) | 59 | $5,863 | $99 |
| Return visit (30+ min) | 40 | $5,143 | $101 |
| X-ray of knee, 3 views | 39 | $1,759 | $37 |
| X-ray of both knees while standing | 40 | $1,570 | $38 |
| X-ray of shoulder blade | 24 | $912 | $33 |
| X-ray of shoulder, minimum of 2 views | 24 | $857 | $31 |
| Injection, methylprednisolone acetate, 80 mg | 44 | $705 | None |
| X-ray of hand, 2 views | 14 | $503 | $30 |
| Injection, dexamethasone sodium phosphate, 1 mg | 28 | $4 | None |
2018: 12 services
| Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg | 14 | $19,484 | None |
| Short return visit (20+ min) | 107 | $12,243 | $62 |
| New patient visit (30+ min) | 85 | $8,010 | $94 |
| Aspiration and/or injection of fluid from large joint | 63 | $7,015 | $46 |
| Return visit (30+ min) | 35 | $3,587 | $97 |
| X-ray of knee, 3 views | 49 | $2,511 | $35 |
| X-ray of both knees while standing | 47 | $1,715 | $35 |
| Injection, methylprednisolone acetate, 80 mg | 47 | $931 | None |
| X-ray of shoulder blade | 27 | $885 | $29 |
| X-ray of shoulder, minimum of 2 views | 27 | $878 | $28 |
| X-ray of hip, 2-3 views | 18 | $649 | $34 |
| Injection, dexamethasone sodium phosphate, 1 mg | 27 | $5 | None |
2017: 12 services
| New patient visit (45+ min) | 100 | $13,956 | $140 |
| Return visit (30+ min) | 53 | $5,918 | $97 |
| Short return visit (20+ min) | 56 | $5,321 | $65 |
| Aspiration and/or injection of fluid from large joint | 48 | $3,478 | $50 |
| New patient visit (30+ min) | 30 | $2,389 | $80 |
| X-ray of knee, 3 views | 34 | $1,594 | $35 |
| X-ray of both knees while standing | 33 | $1,316 | $36 |
| X-ray of shoulder blade | 27 | $1,006 | $30 |
| X-ray of shoulder, minimum of 2 views | 27 | $966 | $28 |
| New patient visit (15+ min) | 14 | $836 | $60 |
| Injection, methylprednisolone acetate, 80 mg | 39 | $539 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 24 | $4 | None |
2016: 4 services
| New patient visit (45+ min) | 16 | $1,676 | $105 |
| New patient visit (30+ min) | 25 | $1,669 | $67 |
| Short return visit (20+ min) | 24 | $1,164 | $47 |
| Aspiration and/or injection of fluid from large joint | 11 | $564 | $47 |
Medicaid work
$918 in 2018
Medicaid paid $918 for 12 billed services this clinician did in 2018, up to 12 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 12 | $918 |
| 2018 | 12 | 1 | 12 | $918 |
Drugs they prescribed that Part D paid
$300
Pharmacies billed $300 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 72% of their Part D prescriptions (21 of 29) in 2024. Too few prescriptions to compare fairly with other clinicians.
29 generic and 0 brand-name prescriptions · $300 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Hydrocodone-Acetaminophen | 16 | $211 | $12 |
Year by year
| 2024 | 29 | 23 | 72% (21) | 0% | $300 |
| 2023 | 39 | 19 | 39% (15) | 0% | $416 |
| 2022 | 41 | 21 | 46% (19) | 0% | $498 |
| 2021 | 31 | 21 | None | None | $276 |
| 2020 | 61 | 26 | 30% (18) | 0% | $584 |
| 2019 | 78 | 35 | 46% (36) | None | $1,667 |
| 2018 | 96 | 54 | 20% (19) | None | $2,503 |
| 2017 | 108 | 63 | 33% (36) | None | $2,019 |
| 2016 | 52 | 34 | None | None | $1,196 |
| 2015 | 258 | 123 | 38% (99) | None | $8,352 |
| 2014 | 219 | 134 | 42% (92) | 5% | $10,409 |
| 2013 | 271 | 147 | 42% (114) | None | $4,725 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 2 drugs
| Hydrocodone-Acetaminophen | 14 | $192 | $14 |
| Meloxicam | 12 | $140 | $12 |
2022: 2 drugs
| Hydrocodone-Acetaminophen | 19 | $282 | $15 |
| Meloxicam | 15 | $142 | $9 |
2021: 1 drug
| Meloxicam | 15 | $38 | $3 |
2020: 2 drugs
| Meloxicam | 35 | $306 | $9 |
| Hydrocodone-Acetaminophen | 17 | $170 | $10 |
2019: 2 drugs
| Hydrocodone-Acetaminophen | 32 | $425 | $13 |
| Meloxicam | 33 | $243 | $7 |
2018: 2 drugs
| Meloxicam | 65 | $641 | $10 |
| Hydrocodone-Acetaminophen | 18 | $362 | $20 |
2017: 2 drugs
| Meloxicam | 60 | $521 | $9 |
| Hydrocodone-Acetaminophen | 29 | $403 | $14 |
2016: 1 drug
| Meloxicam | 37 | $230 | $6 |
2015: 5 drugs
| Hydrocodone-Acetaminophen | 46 | $1,968 | $43 |
| Oxycodone-Acetaminophen | 24 | $1,899 | $79 |
| Meloxicam | 127 | $1,304 | $10 |
| Ibuprofen | 19 | $549 | $29 |
| Acetaminophen-Codeine | 11 | $178 | $16 |
2014: 3 drugs
| Oxycodone-Acetaminophen | 26 | $1,585 | $61 |
| Hydrocodone-Acetaminophen | 51 | $1,191 | $23 |
| Meloxicam | 92 | $965 | $10 |
2013: 2 drugs
| Hydrocodone-Acetaminophen | 92 | $1,536 | $17 |
| Meloxicam | 124 | $1,258 | $10 |
Money from drug and device companies
$60 in 2025
| 2025 | 3 | 3 | None | $60 |
| 2024 | 3 | 7 | $9,000 | $9,133 |
| 2023 | 6 | 7 | None | $189 |
| 2022 | 5 | 9 | None | $301 |
| 2021 | 1 | 1 | None | $17 |
| 2020 | 2 | 2 | None | $42 |
| 2019 | 6 | 7 | None | $142 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Boston Scientific | Wavewriter Alpha Prime 16 | $21 | 1 payment
|
| Anika Therapeutics | Integrity Implant | $20 | 1 payment
|
| Vertex Pharmaceuticals | Journavx | $19 | 1 payment
|
See all 3 published payments
| Boston Scientific | Meals · 2025-09-26 | Wavewriter Alpha Prime 16 | $21 |
| Vertex Pharmaceuticals | Meals · 2025-04-22 | Journavx | $19 |
| Anika Therapeutics | Meals · 2025-03-18 | Integrity Implant | $20 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $9,133
| Pacira Pharmaceuticals | Zilretta | $9,041 | 2 payments
|
| Biotissue Holdings | None | $50 | 3 payments
|
| Vertex Pharmaceuticals | None | $42 | 2 payments
|
2023: $189
| Biotissue Holdings | Neox | $66 | 2 payments
|
| SPR Therapeutics | Sprint Pns System | $30 | 1 payment
|
| Smith+Nephew | Grafix Pl | $25 | 1 payment
|
| Pacira Pharmaceuticals | Exparel | $25 | 1 payment
|
| Orthofix Medical | Physio-Stim | $22 | 1 payment
|
| Fidia Pharma USA | Hymovis | $22 | 1 payment
|
2022: $301
| Allergan | None | $108 | 1 payment
|
| BioTissue Holdings | Neox | $107 | 4 payments
|
| Fidia Pharma USA | Hymovis | $45 | 2 payments
|
| Ethicon US | Stratafix | $21 | 1 payment
|
| Orthofix Medical | Physio-Stim | $19 | 1 payment
|
2021: $17
| DePuy Synthes Sales | Orthovisc | $17 | 1 payment
|
2020: $42
| Baudax Bio | Anjeso | $25 | 1 payment
|
| Endo Pharmaceuticals | Xiaflex | $17 | 1 payment
|
2019: $142
| Stryker | Variax | $40 | 1 payment
|
| Amgen | Evenity | $32 | 1 payment
|
| Bioventus | Exogen | $29 | 1 payment
|
| DePuy Synthes Sales | Monovisc | $15 | 1 payment
|
| Pacira Pharmaceuticals | Exparel | $14 | 1 payment
|
| Fidia Pharma USA | Hymovis | $11 | 2 payments
|
Professional record
- NPI
- 1841571411
- Licence
- CA 116839
- Trained
- University of Southern California Keck School of Medicine, 2006
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Orthopedic surgery (207X00000X)
- Mailing address
- 3043 Meridian Ave Ste 39, San Jose, CA, 95124
- NPI first listed
- 2011-09-08
- NPI last updated
- 2022-04-26
- NPI record certified
- 2022-04-26
This is when the NPI record was last certified, not a medical board exam.